[ABBV]

Mid
보유종목에 대한 모든 정보 확인이 가능합니다. | 원문 보기
Row 2026-08-19 06:11:16
AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition
Mid 2026-08-01 05:29:48
AbbVie forecasts 2026 adjusted EPS of $13.87-$14.07 as it expects ~$67.6B revenue and Q3 EPS of $3.84-$3.88
Row 2026-07-31 21:50:43
4 stocks to watch on Friday: XOM, ABBV, MRNA, and TROW
Row 2026-07-31 21:23:43
AbbVie falls after 2026 guidance cut to reflect Apogee buyout
Mid 2026-07-31 21:12:49
AbbVie in Charts: Skyrizi and Rinvoq fuel growth as Humira decline continues
1 / 4